JAMA Cardiology, published by the American Medical Association, is a leading peer-reviewed journal in the field of cardiology and cardiovascular medicine, with an impressive impact factor signifying its influence and relevance within the medical community. Established in 2016, this journal has quickly gained recognition, currently positioned in the Q1 quartile and ranked #2 out of 387 in its field according to Scopus, reflecting its commitment to high-quality research dissemination. As an esteemed publication, JAMA Cardiology aims to advance the understanding of cardiovascular health through rigorous studies, reviews, and clinical insights. The journal is dedicated to serving a diverse audience of researchers, clinicians, and students, ensuring they have access to groundbreaking findings and comprehensive discussions that shape contemporary cardiology. Although it is not an open-access journal, articles published within it play a pivotal role in informing clinical practice and guiding future research in cardiovascular health, making it an essential resource for anyone engaged in this vital field.

AMERICAN HEART JOURNAL, published by MOSBY-ELSEVIER, stands at the forefront of cardiovascular research, encompassing a vast array of studies focused on heart health, cardiology, and related medical therapies. Established in 1925 and set to continue its legacy into 2024, this esteemed journal holds a prestigious Q1 ranking in the category of Cardiology and Cardiovascular Medicine, reflecting its commitment to quality and significant influence in the field, as evidenced by its 85th percentile ranking in Scopus. With a dedicated readership of researchers, clinicians, and students, the journal serves as a critical platform for sharing groundbreaking findings, innovative techniques, and comprehensive reviews that strive to advance cardiovascular science. Although it does not currently offer open access, the AMERICAN HEART JOURNAL remains an indispensable resource for anyone invested in the evolution and improvement of heart health.

HEART is a leading peer-reviewed journal published by the BMJ Publishing Group, specializing in the field of Cardiology and Cardiovascular Medicine. Established in 1942, the journal has evolved as a premier platform for disseminating high-quality research, innovative practices, and clinical advancements within the cardiovascular domain. With an impressive impact factor and ranked in the Q1 category in 2023, it positions itself among the top-tier journals in its field, boasting a Scopus rank of #37 out of 387 in this highly competitive area, representing the top 10th percentile nationally. The journal supports both traditional and open access options, thereby enhancing the global visibility and reach of its published work. Researchers, professionals, and students alike will find HEART to be an invaluable resource, offering the latest insights and developments that drive the field forward and improve patient care worldwide.

Circulation-Genomic and Precision Medicine is a leading peer-reviewed journal published by Lippincott Williams & Wilkins, dedicated to advancing the fields of cardiology, cardiovascular medicine, and genetics. With an impressive impact factor and ranked in the Q1 quartile across multiple categories, including Cardiology and Genetics, this journal is pivotal for researchers and professionals seeking the latest insights and advancements in precision medicine. Established in 2018, it has rapidly gained recognition, evidenced by its commendable Scopus ranking and high percentiles among related fields. The journal emphasizes open access to enhance the dissemination of knowledge, making cutting-edge research readily available to a global audience. With the convergence of genomic science and cardiovascular health, Circulation-Genomic and Precision Medicine aims to foster interdisciplinary collaborations, offering a vital platform for innovative studies that impact patient care and clinical practices.

The European Journal of Preventive Cardiology, published by Oxford University Press, is a leading international journal dedicated to the field of cardiology and cardiovascular medicine. With an impact factor that underscores its prestige—ranking in the top quartile (Q1) of both cardiology and epidemiology categories—the journal serves as a critical resource for researchers and practitioners seeking to advance their understanding of preventive strategies in cardiovascular health. Since its inception in 1999, it has provided a platform for high-quality research and reviews that address the epidemiology of cardiovascular diseases, risk factor management, and innovative prevention methodologies. Notably, it currently ranks #21 out of 387 in Medicine - Cardiology and #13 out of 148 in Medicine - Epidemiology according to Scopus, highlighting its influential position in these essential biomedical fields. The journal also provides open access options, allowing both readers and authors the opportunity to engage with groundbreaking research and enhance the dissemination of knowledge. With a commitment to excellence, the European Journal of Preventive Cardiology is an invaluable asset for those dedicated to the prevention of cardiovascular diseases.

Frontiers in Cardiovascular Medicine is a leading open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing research in the field of cardiology and cardiovascular medicine. Since its inception in 2014, the journal has become a vital platform for the dissemination of high-quality research, boasting a commendable Q2 rank in the 2023 category for Cardiology and Cardiovascular Medicine. With a focus on promoting innovative studies and clinical insights, Frontiers in Cardiovascular Medicine facilitates open access to its content, allowing researchers, healthcare professionals, and students from around the globe to engage with the latest findings which are critical for the advancement of cardiovascular health. The journal's significant presence in the academic landscape, as indicated by its Scopus ranking (161/387 and 58th percentile), underscores its importance as a research outlet in this essential field. Located in Lausanne, Switzerland, the journal continues to support the global cardiovascular community by encouraging collaboration and knowledge sharing to address the challenges faced in cardiovascular medicine today.

Journal of Cardiology, published by ELSEVIER, stands as a prominent resource in the field of cardiology and cardiovascular medicine. With a rich history since its inception in 1987, this peer-reviewed journal aims to disseminate cutting-edge research that enhances the understanding and treatment of cardiovascular diseases. Its 2023 ranking places it in the Q2 category within its discipline, reflecting its significance and impact, as evidenced by a Scopus rank of #123 out of 387 journals, positioning it in the 68th percentile of its field. The journal is headquartered in Japan, providing a unique perspective on cardiological advances relevant not only to the Asian continent but also globally. Though it does not currently offer open access, the Journal of Cardiology remains a vital institutional resource for researchers, clinicians, and students seeking to push the boundaries of cardiovascular science and improve patient outcomes.

Clinica e Investigacion en Arteriosclerosis is a premier academic journal dedicated to the field of cardiology and cardiovascular medicine, published by ELSEVIER. With its ISSN 0214-9168 and E-ISSN 1578-1879, the journal aims to disseminate high-quality research and innovations in the understanding and treatment of arterial diseases, contributing significantly to both clinical practices and pharmacological advancements. Established in 2007 and continuing into 2024, the journal has garnered recognition with a notable Q3 categorization in both Cardiology and Cardiovascular Medicine and Pharmacology (medical) for 2023, reflecting its impact in the academic community. Researchers and healthcare professionals utilizing this journal will find a diverse range of articles exploring novel therapeutic strategies and epidemiological data, making it an essential resource for advancing knowledge and practice in cardiovascular health. While it does not operate as an open-access journal, the findings published in Clinica e Investigacion en Arteriosclerosis are pivotal for understanding current trends and future directions in cardiovascular research.

Revista de la Federacion Argentina de Cardiologia is a vital publication in the field of Cardiology and Cardiovascular Medicine, providing a platform for researchers and healthcare professionals to share significant findings and innovative concepts since its inception in 2012. Published by the Federacion Argentina Cardiology, this journal specifically addresses contemporary issues and advancements within cardiology, contributing to the scholarly dialogue essential for improving cardiovascular health. Despite being categorized in the Q4 quartile for 2023 and presently ranking #358 out of 387 in its field, the journal remains committed to fostering academic inquiry and disseminating valuable research for both local and global audiences. Although it is not an open-access journal, it strives to balance accessibility with rigorous academic standards, ensuring quality contributions that are critical for practitioners and students alike. The journal’s ongoing evaluation and adaptation in the ever-evolving landscape of cardiology underscore its importance in advancing cardiovascular science and practice.

World Journal of Cardiology, published by BAISHIDENG PUBLISHING GROUP INC, stands out as a pivotal resource in the field of cardiology and cardiovascular medicine. With an ISSN of 1949-8462, this journal serves a global audience, promoting knowledge dissemination and collaboration among researchers, healthcare professionals, and students dedicated to advancing cardiovascular health. The journal demonstrates its credibility and impact in the field by achieving a respectable Q2 ranking in the 2023 category of Cardiology and Cardiovascular Medicine. Notably, it is listed in the Scopus database, ranking #189 out of 387 journals, placing it in the 51st percentile, which underscores its relevance and contribution to contemporary cardiovascular research. Although it operates under a subscription model, the journal provides diverse access options, ensuring that critical findings reach a wide audience. Through its comprehensive scope and commitment to publishing high-quality articles, the World Journal of Cardiology plays a vital role in shaping the future of cardiovascular science, making it an invaluable asset for those involved in this essential discipline.